-
-
-
-
-
-
-
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
-
-
-
-
-
-
-
Mangoceuticals' (MGRX) MGX-0024 delivers 100% respiratory survival in studies
-
-
-
-
-
-
-
Mangoceuticals Announces the Launch of “PeachesRx” - a Women's Telehealth Brand Focused on Personalized Wellness and GLP-1 Weight Loss Treatments
-
-
-
-
-
-
-
Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
-
-
-
-
-
-
-
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
-
-
-
-
-
-
-
MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024
-
-
-
-
-
-
-
Mangoceuticals (MGRX) Wins Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts
-
1,197,972 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

